Call for Papers: Advances in Diabetes and Metabolic Dysfunction
This Collection showcases advances in understanding metabolic dysfunction, highlighting pathways, biomarkers, and novel therapies to accelerate translation into effective treatments.
![]() |
VOOZH | about |
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
This Collection showcases advances in understanding metabolic dysfunction, highlighting pathways, biomarkers, and novel therapies to accelerate translation into effective treatments.
This Collection highlights advances in single-cell omics technologies, emphasizing review articles that explore their biomedical applications and insights into cellular heterogeneity.
This Collection showcases recent advances in cell and gene therapies aimed at treating diseases resistant to conventional approaches, including cancers, autoimmune disorders, and etc.
CRISPR-Cas9 technology has revolutionized biotechnology by providing an efficient, precise, and versatile tool for genome editing.
This Collection welcomes contributions on key metabolic pathways, emerging biomarkers, novel therapeutic targets, and the role of metabolic reprogramming on tumor progression and therapy resistance.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.